Does Ureaplasma spp. cause chronic lung disease of prematurity: Ask the audience?
نویسندگان
چکیده
منابع مشابه
Role of ureaplasma urealyticum in lung disease of prematurity.
AIM To examine the role of Ureaplasma urealyticum colonisation or infection in neonatal lung disease. METHODS Endotracheal aspirates from ventilated infants less than 28 weeks of gestation were cultured for U urealyticum and outcomes compared in infants with positive and negative cultures. RESULTS U urealyticum was isolated from aspirates of 39 of 143 (27%) infants. Respiratory distress syn...
متن کاملThe changing pattern of chronic lung disease of prematurity.
Thirty four infants with chronic lung disease of prematurity were reviewed and divided into two groups on the appearance of the chest radiograph. Type 1 disease (n = 19) was defined as homogeneous or patchy ill defined opacification in the lungs without coarse reticulation, and type 2 disease (n = 11) had the classical appearance of bronchopulmonary dysplasia. Four patients could not be classif...
متن کاملDexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity.
Pulmonary fibrosis results from excessive fibroblast proliferation and increased collagen deposition and occurs in chronic lung disease of prematurity (CLD). Platelet-derived growth factor (PDGF)-BB is mitogenic for fibroblasts and levels are increased in fibrotic lung disorders. Systemic dexamethasone (DEX) treatment improves pulmonary function and reduces inflammation in infants with or at ri...
متن کاملRespiratory medication adherence in chronic lung disease of prematurity.
BACKGROUND Chronic lung disease of prematurity (CLDP) is a frequent complication of premature birth. Infants and children with CLDP are often prescribed complex medication regimens, which can be difficult for families to manage. OBJECTIVE We sought to determine whether non-adherence was associated with increased CLDP-related morbidities and to identify predictors of adherence. METHODS Recru...
متن کاملAsk the expert - diffuse interstitial lung disease
HRCT is now a key diagnostic tool in diffuse lung disease, but has not completely replaced histopathological diagnosis. In many cases, HRCT can provide disease-specific information so biopsy can be avoided when the clinical presentation is characteristic [1]. This is relevant for some rarer interstitial lung diseases, such as lymphangioleiomyomatosis (LAM; multiple uniform thin-walled cysts; di...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Early Human Development
سال: 2009
ISSN: 0378-3782
DOI: 10.1016/j.earlhumdev.2008.12.002